Your session is about to expire
← Back to Search
Telehealthcare MTM for Asthma (MATCH Trial)
MATCH Trial Summary
This trial is testing whether using telehealthcare to improve medication adherence will change health outcomes in adolescents and young adults with asthma who have poor adherence with prescribed inhaled corticosteroid therapy.
MATCH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMATCH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MATCH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 12 and 35 years old.My asthma limits my activities or my Asthma Control Test score is 19 or less.I use my rescue inhaler more than twice a week for symptoms.My asthma is uncontrolled, showing symptoms or limitations frequently.You have a low or moderate score on the 7-item ARMS questionnaire for medication adherence.I have been diagnosed with asthma and have no other lung diseases.I experience asthma symptoms more than twice a week during the day.You must have used the Propeller sensor consistently for 4 weeks before the trial.You have taken a new, unapproved treatment in the last 30 days.I have been on inhaled corticosteroids for at least 3 months.I use an albuterol inhaler for sudden asthma symptoms.I speak English or Spanish.My inhaler is not compatible with the Propeller sensor.
- Group 1: EAM only
- Group 2: MTM-EAM
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals currently being accepted for participation in this clinical trial?
"As documented on clinicaltrials.gov, this research trial is actively recruiting with a start date of November 18th 2019 and an edit as recent as August 24th 2022."
How many participants have been recruited to take part in this research project?
"This medical research requires 300 participants that fulfill the specified criteria. Rush University Medical Centre in Chicago, Illinois and University of Illinois at Chicago in Kansas City, Kansas are two sites where these patients can take part."
How many locations are involved in the implementation of this clinical trial?
"Patients may register for this trial at Rush University Medical Center in Chicago, Illinois and the University of Illinois at Chicago in Kansas City, Kansas. Moreover, New york's University of Kansas Medical Centre is also participating as one of 23 other recruitment sites."
Is there a way I can become involved in this experiment?
"This clinical trial seeks out 300 young adults aged 12-35 who have physician diagnosed asthma, suffer from activity limitations due to their condition, need a rescue inhaler more than twice per week, and score greater than 8 on the Adherence to Refills and Medication Scale (ARMS) 7-item questionnaire. Furthermore, they must experience daytime symptoms of asthma more often than not and awaken at night due to their disease."
Is the age eligibility for this research limited to those over 55 years old?
"This clinical trial has a minimum age of 12 and an upper limit for enrolment set at 35 years old."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger